Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Acute and chronic effect of bariatric surgery on circulating autotaxin levels.

Bourgeois R, Piché ME, Auclair A, Grenier-Larouche T, Mitchell PL, Poirier P, Biertho L, Marceau S, Hould FS, Biron S, Lebel S, Lescelleur O, Julien F, Martin J, Tchernof A, Mathieu P, Carpentier AC, Arsenault BJ.

Physiol Rep. 2019 Mar;7(5):e14004. doi: 10.14814/phy2.14004.

2.

Blood Pressure Measurement in Severely Obese Patients: Validation of the Forearm Approach in Different Arm Positions.

Leblanc MÈ, Auclair A, Leclerc J, Bussières J, Agharazii M, Hould FS, Marceau S, Brassard P, Godbout C, Grenier A, Cloutier L, Poirier P.

Am J Hypertens. 2019 Jan 15;32(2):175-185. doi: 10.1093/ajh/hpy152.

PMID:
30312368
3.

Safety of Blood Glucose Response Following Exercise Training After Bariatric Surgery.

Proulx É, Auclair A, Piché ME, Harvey J, Pettigrew M, Biertho L, Marceau S, Poirier P.

Obes Surg. 2018 Dec;28(12):3976-3983. doi: 10.1007/s11695-018-3449-8.

PMID:
30097897
4.

NLX-112, a highly selective 5-HT1A receptor agonist, mediates analgesia and antidepressant-like activity in rats via spinal cord and prefrontal cortex 5-HT1A receptors, respectively.

Newman-Tancredi A, Bardin L, Auclair A, Colpaert F, Depoortère R, Varney MA.

Brain Res. 2018 Jun 1;1688:1-7. doi: 10.1016/j.brainres.2018.03.016. Epub 2018 Mar 16.

PMID:
29555239
5.

Acute and Chronic Impact of Bariatric Surgery on Plasma LDL Cholesterol and PCSK9 Levels in Patients With Severe Obesity.

Boyer M, Piché ME, Auclair A, Grenier-Larouche T, Biertho L, Marceau S, Hould FS, Biron S, Lebel S, Lescelleur O, Julien F, Martin J, Tchernof A, Carpentier AC, Poirier P, Arsenault BJ.

J Clin Endocrinol Metab. 2017 Nov 1;102(11):4023-4030. doi: 10.1210/jc.2017-00699.

PMID:
28938493
6.

Bariatric Surgery-Induced Lower Angiopoietin-Like 2 Protein Is Associated With Improved Cardiometabolic Profile.

Piché ME, Thorin-Trescases N, Auclair A, Marceau S, Martin J, Fortier A, Thorin E, Poirier P.

Can J Cardiol. 2017 Aug;33(8):1044-1051. doi: 10.1016/j.cjca.2017.05.023. Epub 2017 Jun 2.

PMID:
28754390
7.

Effect of bariatric surgery on heart failure.

Rodriguez Flores M, Aguilar Salinas C, Piché ME, Auclair A, Poirier P.

Expert Rev Cardiovasc Ther. 2017 Aug;15(8):567-579. doi: 10.1080/14779072.2017.1352471. Epub 2017 Jul 27. Review.

PMID:
28714796
8.

Bariatric Surgery-Induced Resolution of Hypertension and Obstructive Sleep Apnea: Impact of Modulation of Body Fat, Ectopic Fat, Autonomic Nervous Activity, Inflammatory and Adipokine Profiles.

Auclair A, Biertho L, Marceau S, Hould FS, Biron S, Lebel S, Julien F, Lescelleur O, Lacasse Y, Piché ME, Cianflone K, Parlee SD, Goralski K, Martin J, Bastien M, St-Pierre DH, Poirier P.

Obes Surg. 2017 Dec;27(12):3156-3164. doi: 10.1007/s11695-017-2737-z.

PMID:
28555408
9.

Determinants of Improvement In Left Ventricular Diastolic Function Following a 1-Year Lifestyle Modification Program in Abdominally Obese Men with Features of the Metabolic Syndrome.

Leclerc J, Arsenault M, Després JP, Brassard P, Gaudreault V, Bergeron J, Alméras N, Tremblay A, Auclair A, Ross MK, Denault-Bissonnette S, Poirier P.

Metab Syndr Relat Disord. 2016 Dec;14(10):483-491. Epub 2016 Oct 18.

PMID:
27754772
10.

Is There a Role for Visceral Adiposity in Inducing Type 2 Diabetes Remission in Severely Obese Patients Following Biliopancreatic Diversion with Duodenal Switch Surgery?

Auclair A, Martin J, Bastien M, Bonneville N, Biertho L, Marceau S, Hould FS, Biron S, Lebel S, Lescelleur O, Després JP, Poirier P.

Obes Surg. 2016 Aug;26(8):1717-27. doi: 10.1007/s11695-015-1973-3.

PMID:
26660319
11.

How to choose and use bariatric surgery in 2015.

Piché MÈ, Auclair A, Harvey J, Marceau S, Poirier P.

Can J Cardiol. 2015 Feb;31(2):153-66. doi: 10.1016/j.cjca.2014.12.014. Epub 2014 Dec 15. Review.

PMID:
25661550
12.

If not dieting, how to lose weight? Tips and tricks for a better global and cardiovascular health.

Leclerc J, Bonneville N, Auclair A, Bastien M, Leblanc ME, Poirier P.

Postgrad Med. 2015 Mar;127(2):173-85. doi: 10.1080/00325481.2015.993884. Epub 2014 Dec 24. Review.

PMID:
25539643
13.

Pathogenic Landscape of Transboundary Zoonotic Diseases in the Mexico-US Border Along the Rio Grande.

Esteve-Gassent MD, Pérez de León AA, Romero-Salas D, Feria-Arroyo TP, Patino R, Castro-Arellano I, Gordillo-Pérez G, Auclair A, Goolsby J, Rodriguez-Vivas RI, Estrada-Franco JG.

Front Public Health. 2014 Nov 17;2:177. doi: 10.3389/fpubh.2014.00177. eCollection 2014. Review.

14.

Omentin changes following bariatric surgery and predictive links with biomarkers for risk of cardiovascular disease.

Lapointe M, Poirier P, Martin J, Bastien M, Auclair A, Cianflone K.

Cardiovasc Diabetol. 2014 Aug 21;13:124. doi: 10.1186/s12933-014-0124-9.

15.

Role of bariatric surgery in diabetes.

Poirier P, Auclair A.

Curr Cardiol Rep. 2014 Feb;16(2):444. doi: 10.1007/s11886-013-0444-5. Review.

PMID:
24408672
16.

Daily steps threshold to improve cardiovascular disease risk factors during the year after an acute coronary syndrome.

Houle J, Valera B, Gaudet-Savard T, Auclair A, Poirier P.

J Cardiopulm Rehabil Prev. 2013 Nov-Dec;33(6):406-10. doi: 10.1097/HCR.0000000000000021.

PMID:
24104407
17.

Levomilnacipran (F2695), a norepinephrine-preferring SNRI: profile in vitro and in models of depression and anxiety.

Auclair AL, Martel JC, Assié MB, Bardin L, Heusler P, Cussac D, Marien M, Newman-Tancredi A, O'Connor JA, Depoortère R.

Neuropharmacology. 2013 Jul;70:338-47. doi: 10.1016/j.neuropharm.2013.02.024. Epub 2013 Mar 13.

18.

[Assessment of the check-list in the operating room: perceptions of caregivers and physicians (level II assessment)].

Hacquard P, Cunat C, Toussaint C, Auclair A, Malecot MA, Ginet MF, Brun P, Pecquerie N, Lifante JC, Flatin V, Piriou V.

Ann Fr Anesth Reanim. 2013 Apr;32(4):235-40. doi: 10.1016/j.annfar.2013.01.021. Epub 2013 Mar 13. French.

PMID:
23498557
19.

Integrated Strategy for Sustainable Cattle Fever Tick Eradication in USA is Required to Mitigate the Impact of Global Change.

Pérez de León AA, Teel PD, Auclair AN, Messenger MT, Guerrero FD, Schuster G, Miller RJ.

Front Physiol. 2012 Jun 14;3:195. doi: 10.3389/fphys.2012.00195. eCollection 2012.

20.

The central serotonin 2B receptor: a new pharmacological target to modulate the mesoaccumbens dopaminergic pathway activity.

Auclair AL, Cathala A, Sarrazin F, Depoortère R, Piazza PV, Newman-Tancredi A, Spampinato U.

J Neurochem. 2010 Sep 1;114(5):1323-32. doi: 10.1111/j.1471-4159.2010.06848.x. Epub 2010 Jun 7.

21.

F15599, a preferential post-synaptic 5-HT1A receptor agonist: activity in models of cognition in comparison with reference 5-HT1A receptor agonists.

Depoortère R, Auclair AL, Bardin L, Colpaert FC, Vacher B, Newman-Tancredi A.

Eur Neuropsychopharmacol. 2010 Sep;20(9):641-54. doi: 10.1016/j.euroneuro.2010.04.005. Epub 2010 May 21.

PMID:
20488670
22.

F15599, a highly selective post-synaptic 5-HT(1A) receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity.

Assié MB, Bardin L, Auclair AL, Carilla-Durand E, Depoortère R, Koek W, Kleven MS, Colpaert F, Vacher B, Newman-Tancredi A.

Int J Neuropsychopharmacol. 2010 Nov;13(10):1285-98. doi: 10.1017/S1461145709991222. Epub 2010 Jan 11.

PMID:
20059805
23.

Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys.

Auclair AL, Kleven MS, Barret-Grévoz C, Barreto M, Newman-Tancredi A, Depoortère R.

Behav Brain Res. 2009 Nov 5;203(2):288-95. doi: 10.1016/j.bbr.2009.05.015. Epub 2009 May 21.

PMID:
19464324
24.

The five choice serial reaction time task: comparison between Sprague-Dawley and Long-Evans rats on acquisition of task, and sensitivity to phencyclidine.

Auclair AL, Besnard J, Newman-Tancredi A, Depoortère R.

Pharmacol Biochem Behav. 2009 Apr;92(2):363-9.

PMID:
19353758
25.

Interest of an objective evaluation of cough during weaning from mechanical ventilation.

Beuret P, Roux C, Auclair A, Nourdine K, Kaaki M, Carton MJ.

Intensive Care Med. 2009 Jun;35(6):1090-3. doi: 10.1007/s00134-009-1404-9. Epub 2009 Jan 24.

PMID:
19169666
26.

Effects of antipsychotics and reference monoaminergic ligands on marble burying behavior in mice.

Bruins Slot LA, Bardin L, Auclair AL, Depoortere R, Newman-Tancredi A.

Behav Pharmacol. 2008 Mar;19(2):145-52. doi: 10.1097/FBP.0b013e3282f62cb2.

PMID:
18332679
27.

F15063, a potential antipsychotic with dopamine D(2)/D(3) antagonist, 5-HT(1A) agonist and D(4) partial agonist properties: (IV) duration of brain D2-like receptor occupancy and antipsychotic-like activity versus plasma concentration in mice.

Assié MB, Bardin L, Auclair A, Consul-Denjean N, Sautel F, Depoortère R, Newman-Tancredi A.

Naunyn Schmiedebergs Arch Pharmacol. 2007 Jun;375(4):241-50. Epub 2007 Apr 24.

PMID:
17453175
28.

Putative antipsychotics with pronounced agonism at serotonin 5-HT1A and partial agonist activity at dopamine D2 receptors disrupt basal PPI of the startle reflex in rats.

Auclair AL, Galinier A, Besnard J, Newman-Tancredi A, Depoortère R.

Psychopharmacology (Berl). 2007 Jul;193(1):45-54. Epub 2007 Mar 29.

PMID:
17393144
29.

F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia.

Depoortère R, Bardin L, Auclair AL, Kleven MS, Prinssen E, Colpaert F, Vacher B, Newman-Tancredi A.

Br J Pharmacol. 2007 May;151(2):253-65. Epub 2007 Mar 20.

30.

F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms.

Depoortère R, Auclair AL, Bardin L, Bruins Slot L, Kleven MS, Colpaert F, Vacher B, Newman-Tancredi A.

Br J Pharmacol. 2007 May;151(2):266-77. Epub 2007 Mar 20.

31.

Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics.

Bardin L, Auclair A, Kleven MS, Prinssen EP, Koek W, Newman-Tancredi A, Depoortère R.

Behav Pharmacol. 2007 Mar;18(2):103-18.

PMID:
17351418
32.
33.

Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.

Auclair AL, Kleven MS, Besnard J, Depoortère R, Newman-Tancredi A.

Neuropsychopharmacology. 2006 Sep;31(9):1900-9. Epub 2006 Jan 18.

35.
36.
37.

Presenilin-1 is indirectly implicated in Notch1 cleavage.

Godin C, Auclair A, Ferland M, Hébert SS, Carreau M, Lévesque G.

Neuroreport. 2003 Aug 26;14(12):1613-6.

PMID:
14502086
39.

Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors.

Dekeyne A, Gobert A, Auclair A, Girardon S, Millan MJ.

Psychopharmacology (Berl). 2002 Jul;162(2):156-67. Epub 2002 May 1.

PMID:
12110993
40.
41.

S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine.

Millan MJ, Lejeune F, Gobert A, Brocco M, Auclair A, Bosc C, Rivet JM, Lacoste JM, Cordi A, Dekeyne A.

J Pharmacol Exp Ther. 2000 Dec;295(3):1206-22.

PMID:
11082458
42.

Microfungal variations relative to post-fire changes in soil environment.

Lucarotti CJ, Kelsey CT, Auclair AN.

Oecologia. 1978 Jan;37(1):1-12. doi: 10.1007/BF00349986.

PMID:
28309280
43.

Factors affecting tissue nutrient concentrations in aCarex meadow.

Auclair AN.

Oecologia. 1977 Sep;28(3):233-246. doi: 10.1007/BF00751602.

PMID:
28309249
44.

Productivity relations in a Carex-dominated ecosystem.

Auclair AN, Bouchard A, Pajaczkowski J.

Oecologia. 1976 Mar;26(1):9-31. doi: 10.1007/BF00345650.

PMID:
28309101

Supplemental Content

Loading ...
Support Center